Product Description: Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Kapur S, et, al. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes. P T. 2009 Mar;34(3):138-41.
CAS Number: 501081-76-1
Molecular Weight: N/A
Compound Purity: 95.0
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Interleukin Related